(Q45345173)

English

Identification and characterization of an inhibitory fibroblast growth factor receptor 2 (FGFR2) molecule, up-regulated in an Apert Syndrome mouse model

scientific article published in May 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Identification and characterization of an inhibitory fibroblast growth factor receptor 2 (FGFR2) molecule, up-regulated in an Apert Syndrome mouse model (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

author name string

Lee M Wheldon

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Naila Khodabukus

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Susannah J Patey

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Terence G Smith

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Mohammad K Hajihosseini

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Biochemical Journal

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

436

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

71-81

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Fgf10 is essential for limb and lung formation

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

An Fgf8 mutant allelic series generated by Cre- and Flp-mediated recombination

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Fibroblast growth factor signaling in cranial suture development and pathogenesis

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Bad bones, absent smell, selfish testes: the pleiotropic consequences of human FGF receptor mutations

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

The FGF family: biology, pathophysiology and therapy

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Skeletal development is regulated by fibroblast growth factor receptor 1 signalling dynamics.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Promotion and attenuation of FGF signaling through the Ras-MAPK pathway

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Critical role of FLRT1 phosphorylation in the interdependent regulation of FLRT1 function and FGF receptor signalling

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Association of the signaling adaptor FRS2 with fibroblast growth factor receptor 1 (Fgfr1) is mediated by alternative splicing of the juxtamembrane domain

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Structural characterization of the circulating soluble FGF receptors reveals multiple isoforms generated by secretion and ectodomain shedding

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Nonsense-mediated mRNA decay in mammals

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

A splicing switch and gain-of-function mutation in FgfR2-IIIc hemizygotes causes Apert/Pfeiffer-syndrome-like phenotypes

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Rare mutations of FGFR2 causing apert syndrome: identification of the first partial gene deletion, and an Alu element insertion from a new subfamily

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Evidence that Fgf10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

A subset of fibroblast growth factors (Fgfs) promote survival, but Fgf-8b specifically promotes astroglial differentiation of rat cortical precursor cells

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Feedback interactions between MKP3 and ERK MAP kinase control scleraxis expression and the specification of rib progenitors in the developing chick somite

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Fibroblast growth factor receptor 3 lacking the Ig IIIb and transmembrane domains secreted from human squamous cell carcinoma DJM-1 binds to FGFs

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

The nonsense-mediated decay pathway and mutually exclusive expression of alternatively spliced FGFR2IIIb and -IIIc mRNAs

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Argos inhibits epidermal growth factor receptor signalling by ligand sequestration

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Secreted antagonists of the Wnt signalling pathway

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

N-glycosylation of fibroblast growth factor receptor 1 regulates ligand and heparan sulfate co-receptor binding

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

N-Glycosylation regulates fibroblast growth factor receptor/EGL-15 activity in Caenorhabditis elegans in vivo

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Fibroblast growth factor 10 (Fgf10) invalidation results in anorectal malformation in mice

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalities

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

A soluble form of fibroblast growth factor receptor 2 (FGFR2) with S252W mutation acts as an efficient inhibitor for the enhanced osteoblastic differentiation caused by FGFR2 activation in Apert syndrome

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Identification of a novel alternative splicing of human FGF receptor 4: soluble-form splice variant expressed in human gastrointestinal epithelial cells.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

A soluble dominant negative fibroblast growth factor receptor 4 isoform in human MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Identification and characterization of soluble isoform of fibroblast growth factor receptor 3 in human SaOS-2 osteosarcoma cells

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Tumour suppressive properties of fibroblast growth factor receptor 2-IIIb in human bladder cancer

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas.

1 reference

https://api.crossref.org/works/10.1042%2FBJ20100884

21 January 2018

Identifiers

10.1042/BJ20100884

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45345173&oldid=2075432527"